We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Failure to Follow Trial Plans Lands Investigators FDA Warnings
Failure to Follow Trial Plans Lands Investigators FDA Warnings
July 10, 2014
A Georgia clinical investigator was warned by the FDA for failing to properly randomize and dose patients participating in a GlaxoSmithKline study evaluating albiglutide in patients with type 2 diabetes.